Trump Signs Order to Reschedule Cannabis - Retail Investors Should Be Careful

Key Concepts

• Schedule I, II, & III (Drug Scheduling): Refers to the classification of drugs under the Controlled Substances Act, impacting their legal status and accessibility. Schedule I drugs have no currently accepted medical use and high potential for abuse, while Schedule III have a potential for abuse less than Schedule I or II and have currently accepted medical use.
• 280E: Section 280E of the Internal Revenue Code disallows business expenses for businesses trafficking in Schedule I or II controlled substances. This significantly impacts cannabis companies’ profitability.
• MSOS: Refers to a cannabis ETF (Exchange Traded Fund) – AdvisorShares MSOS ETF – tracking companies involved in the cannabis industry in the United States.
• Retail Investors: Individual, non-professional investors who buy and sell securities for their own account.

The Current Status of Federal Cannabis Rescheduling & Investor Risk

The video focuses on the current situation regarding potential federal rescheduling of cannabis in the United States, specifically addressing the impact on investor expectations and the risks associated with speculative trading. The core message is a caution against premature assumptions about the timing and outcome of rescheduling, particularly for retail investors.

The speaker clarifies that the widely discussed possibility of cannabis being moved to Schedule II is not what Donald Trump is currently considering. This directly contradicts a prevalent rumor circulating within the investment community. Instead, the focus appears to be on a move to Schedule III, though even this is not a certainty. The speaker emphasizes, “Trump is not interested in schedule two, which was a rumor that was out there.”

Price Action & Investor Sentiment

The video highlights a recent market reaction – a price drop in cannabis stocks – following the initial rumor of potential action by Trump. This price decline fell below the price point of the MSOS ETF when the initial rumor surfaced. This is presented as evidence of the volatility and potential for miscalculation within the sector. The speaker observes that many on Twitter expressed surprise at this price action, demonstrating a disconnect between investor expectations and market reality.

The Danger of “Consensus Trades”

A central argument is the danger of following “consensus trades” – investments that appear universally favorable. The speaker warns that even seemingly safe bets can lead to losses. The statement, “You really can get burned playing the trade that kind of everybody agrees is the is the good trade,” underscores this point. This is attributed to the tendency for market prices to reflect anticipated events before they actually occur, leaving little room for further gains once the news breaks. The speaker suggests that investors are “pulling forward” future expectations with undue certainty.

Implications for Retail Investors

The video specifically targets retail investors, urging them to exercise extreme caution. The speaker believes they are particularly vulnerable to being burned by speculative trading based on incomplete or inaccurate information. The volatility of the cannabis sector, coupled with the potential for rapid shifts in sentiment, makes it a risky environment for those who are not closely monitoring developments and understanding the nuances of the situation.

Logical Connections & Synthesis

The video establishes a clear connection between the evolving regulatory landscape (potential rescheduling), investor expectations, and market price action. The speaker uses the recent price drop as a concrete example to illustrate the risks of acting on rumors and overestimating the speed of regulatory change. The overall takeaway is a call for realistic expectations and a cautious approach to investing in the cannabis sector, particularly in anticipation of federal rescheduling. The speaker doesn’t dismiss the possibility of rescheduling, but stresses that it’s not a foregone conclusion and that the market is already pricing in a significant degree of optimism.